Article Name Predictive Diagnostics
New microelectrothermoforming (μETF) method improves neural recording and stimulation, with applications in artificial retinas and brain-computer interfaces.
28th February, 2025
Six-month study demonstrates 85% symptom reduction and strong safety profile, advancing a minimally invasive solution for urgency urinary incontinence treatment.
27th February, 2025
The initiative enhances medical education by equipping healthcare professionals with advanced Microwave Ablation techniques to improve cancer treatment outcomes worldwide.
27th February, 2025
The initiative strengthens opioid prevention across Alabama by providing communities with vital education and at-home medication disposal solutions to reduce misuse and accidental overdoses.
27th February, 2025
The collaboration enhances Esco's IVF instrument portfolio with Allwin's consumables, offering a comprehensive solution for IVF clinicians and embryologists while expanding market presence in India.
26th February, 2025
Regulatory green light follows IMROZ Phase 3 study results showing significant progression-free survival benefit
25th February, 2025
The new 2 mL pre-filled pen option expands individualized treatment choices for hereditary angioedema (HAE) patients, reinforcing Takeda’s commitment to reducing disease burden and improving quality of life.
25th February, 2025
With plans to commercialize its pancreatic cancer test in the U.S. by late 2025, Immunovia seeks financial leadership with diagnostics expertise and global capital market experience.
24th February, 2025
Following constructive discussions with the FDA, Co-Dx shifts focus to an improved test submission, incorporating platform advancements and optimizing long-term performance.
24th February, 2025
With all female patients in its groundbreaking clinical feasibility study reaching six-month primary endpoints, UroMems' UroActive System marks a transformative step in treating stress urinary incontinence. The AI-powered smart implant, designed to enhance patient quality of life, is now paving the way for expanded adoption in the U.S. and Europe.
21st February, 2025
3Shape is celebrating 25 years of innovation by introducing a paradigm shift in CAD workflows for dental labs with the upcoming release of 3Shape Dental System 2024. This new software update will include a free AI-driven crown design application along with several workflow enhancements to significantly improve efficiency and digitization for dental labs. As the first employee hired at 3Shape 25 years ago, Rune Fisker, Senior Vice President of Product Strategy, reflects on the remarkable evolution of CAD/CAM technology from a visionary concept to an industry standard. He emphasizes the growing adoption of digital workflows and the necessity for lab technicians to experience the speed, automation, and convenience of the new Dental System 2024 software. Unveiled at LMT Lab Day and the upcoming IDS in Germany, 3Shape Dental System 2024 introduces several groundbreaking upgrades. Labs will now have access to AI-powered design proposals for crowns, inlays, and onlays at no additional cost with a 3Shape LabCare subscription. This feature eliminates the need for manual setup and ensures high-quality editable designs that streamline case management. The software also boosts efficiency with up to 10x faster case processing, 20x faster case reopening, and AI automation for routine tasks such as occlusal plane positioning and segmentation. Further enhancements include a seamless integration between 3Shape LMS and Dental System to reduce administrative workload and improve data accuracy. The new TRIOS ioConnect Workflow for All-on-X treatments simplifies full-arch restorations, integrating TruAbutment's ioConnect elongated abutments with 3Shape's software and intraoral scanners. Additionally, 3Shape is eliminating physical software license dongles in favor of cloud-based licensing, ensuring easier updates and real-time access to purchased software. Dental System 2024 marks a new era in digital dentistry, empowering dental labs with cutting-edge AI-driven tools, seamless integrations, and enhanced automation. By prioritizing speed, accuracy, and convenience, 3Shape continues to push the boundaries of digital innovation, allowing lab professionals to focus on delivering exceptional service to their clients.
21st February, 2025
With its innovative, technology-driven model, Encore Wound Care extends its footprint to Tennessee, enhancing clinical outcomes, optimizing facility operations, and treating over 10,000 wounds per week across its growing service regions.
20th February, 2025
With groundbreaking ultrasound-based solutions for brain cancer and drug-resistant epilepsy, NaviFUS expands its global impact through strategic industry collaborations, clinical breakthroughs, and partnerships with leading healthcare innovators.
20th February, 2025
LiS Academy, an independent academic forum led by top oncologists, aims to enhance awareness and adoption of liquid biopsies for personalized cancer care in India.
19th February, 2025
Designed for emergency settings, the new tray features the Ultraplex® 360 Needle with advanced echogenic technology, enabling precise regional anesthesia as a safer alternative to opioids.
19th February, 2025
Largest Randomized AI Mammography Study Shows 29% Higher Cancer Detection with 44% Less Screen-Reading Burden
18th February, 2025
By compressing decades of medical discoveries into a single day, NeuralCure AI’s cutting-edge platform accelerates treatment breakthroughs for complex diseases. The company launches a new funding round to expand AI-driven diagnostics and personalized medicine on a global scale.
17th February, 2025
The first-of-its-kind system, designed specifically for neonatal and pediatric patients, leverages real-time ECG signal analysis to improve CVAD placement, enhance patient safety, and reduce complications, marking a major milestone in global pediatric healthcare.
17th February, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer